Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Partial Epilepsy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00141414
What this trial is testing

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Who this might be right for
Epilepsy, Partial
Pfizer 82
Large-scale testing (Phase 3)Ended earlyNCT00448539
What this trial is testing

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Who this might be right for
Refractory Partial Onset Seizures
Eisai Inc. 286
Not applicableLooking for participantsNCT06212609
What this trial is testing

Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies

Who this might be right for
Transcranial Electric StimulationtDCSEpilepsy+3 more
Centre Hospitalier Universitaire, Amiens 20
Post-approval studies (Phase 4)Ended earlyNCT02727101
What this trial is testing

Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

Who this might be right for
Epilepsy
Mid-Atlantic Epilepsy and Sleep Center, LLC 8
Not applicableUnknownNCT03321240
What this trial is testing

Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia

Who this might be right for
Refractory EpilepsyFocal EpilepsyFocal Cortical Dysplasia
University Hospital, Strasbourg, France 240
Not applicableEnded earlyNCT03955432
What this trial is testing

Long-term Cardiac Monitoring in Epilepsy

Who this might be right for
Focal EpilepsyIntractable EpilepsyEpileptic Encephalopathy+3 more
Northwell Health 7
Testing effectiveness (Phase 2)Study completedNCT00105040
What this trial is testing

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB Pharma 87
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Not applicableStudy completedNCT03446664
What this trial is testing

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Who this might be right for
Epilepsies, PartialEpilepsy, Tonic-Clonic
LivaNova 33
Testing effectiveness (Phase 2)Study completedNCT00368472
What this trial is testing

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 138
Large-scale testing (Phase 3)Study completedNCT01713946
What this trial is testing

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Who this might be right for
Tuberous Sclerosis Complex-associated Refractory Seizures
Novartis Pharmaceuticals 366
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT00228969
What this trial is testing

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

Who this might be right for
Refractory Epilepsy
SK Life Science, Inc.
Testing effectiveness (Phase 2)Study completedNCT00210522
What this trial is testing

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 421
Not applicableWithdrawnNCT02513992
What this trial is testing

Ictal SPECT With Intra-arterial Injection

Who this might be right for
Epilepsy
Universitaire Ziekenhuizen KU Leuven
Not applicableStudy completedNCT04770337
What this trial is testing

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory EpilepsyFocal SeizureSeizures, Focal+4 more
Neuroelectrics Corporation 127
Not applicableActive Not RecruitingNCT06681480
What this trial is testing

Transcranial Magnetic Stimulation (rTMS) for Refractory Focal Epilepsy

Who this might be right for
Focal EpilepsyTranscranial Magnetis Stimulation
Comenius University 20
Large-scale testing (Phase 3)Study completedNCT01191086
What this trial is testing

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 210
Early research (Phase 1)UnknownNCT03024827
What this trial is testing

Cannabidiol in Children With Refractory Epileptic Encephalopathy

Who this might be right for
Epileptic Encephalopathy
University of Saskatchewan 20
Testing effectiveness (Phase 2)WithdrawnNCT00567424
What this trial is testing

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline
Next Page